Hi, what are you looking for?
Jewish Business News
Search results for "FBI"
StartUps
– The 12-week Phase IIb study involving 79 patients with active rheumatoid arthritis met all its primary efficacy endpoints. – Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin...
Money
– CEO Dr. Pnina Fishman Can-Fite BioPharma Ltd. (NYSE MKT: CANF), (TASE: CFBI), CEO Dr. Pnina Fishman will ring The Opening Bell at the...
Money
– The cancer and inflammatory drug development company will list its Level II ADRs on the NYSE MKT on Tuesday , November 19, 2013...
Entertainment
– Old City Jerusalem – The USA Network is getting ready to produce what it hopes to be a block-buster new drama series to...
StartUps
– Can-Fite BioPharma Ltd. (TASE: CFBI), (OTCQB: CANFY) and its subsidiary, OphthaliX Inc. (OTCQB: OPLI), jointly announced today that the U.S. Patent and Trademark Office...
VC, Investments
– Can-Fite will use the proceeds to increase its shareholders’ equity to meet the criteria for listing its ADRs on the NYSE. – Can-Fite...
IPOs
– Enzymotec, which has developed a proprietary method for processing fatty acids, is seeking to raise $75 million. – – / By Gali Weinreb...
Court
– U.S. Attorney for the Southern District of New York Preet Bharara and Assistant Director-in-Charge of the New York Field Office of the FBI...
Court
– Steven Cohen / Getty – / By Clive Minchom/ On July 19th, 2013 The Securities and Exchange Commission (SEC) announced civil charges against...
IPOs
– Can-Fite Eye Disease spin-off hopes to raise up to US$10 million on NYSE. Road show starts in July. – Can-Fite CEO Pnina Fishman...